Exam Details
Subject | pharmaceutical formulation development and biopharmceutics | |
Paper | ||
Exam / Course | m.pharm | |
Department | ||
Organization | Gujarat Technological University | |
Position | ||
Exam Date | May, 2018 | |
City, State | gujarat, ahmedabad |
Question Paper
Seat No.: Enrolment No.
GUJARAT TECHNOLOGICAL UNIVERSITY
M. Ph. SEMESTER I EXAMINATION SUMMER 2018
Subject Code: 910102 Date: 05/05/2018
Subject Name: PHARMACEUTICAL FORMULATION DEVELOPMENT
BIOPHARMACEUTICS
Time: 02:30PM TO 05:30PM Total Marks: 80
Instructions:
1. Attempt any five questions.
2. Make suitable assumptions wherever necessary.
3. Figures to the right indicate full marks.
Q.1
Discuss hydrotrophy with respect to solubilization.
06
Discuss drug excipients compatibility study in context to preformulation studies.
05
Discuss the importance of dissolution study and enlist various dissolution test apparatus as per IP and USP respectively.
05
Q.2
Explain biological half life and total body clearance in context to pharmacokinetic parameters.
06
Enumerate the pharmaceutical factors affecting drug absorption and discuss disintegration time in said context.
05
Write the objectives of stability study and enumerate the factors affecting stability of formulation.
05
Q.3
Discuss formulation of tooth paste.
06
Write a note on levels of IVIVC.
05
Discuss the rationale for selecting preferred polymorphs/crystalline form with respect to preformulation study.
05
Q.4
Write a note on compartment models.
06
Explain four classes of BCS.
05
Explain "Order of reaction". Define zero order reaction and first order reaction and write examples and equation for calculating half life for each.
05
Q.5
Enumerate the methods of studying bioavailability and with the help of diagram, explain the importance of three major parameters of urinary excretion data obtained with single dose study.
06
Write the criteria for obtaining valid urinary excretion data.
05
Define IVIVC and discus its purposes.
05
Q. 6
Define preformulation and write the objectives of preformulation studies.
Give full forms of the following: DSC XRD FTIR OVIs DTA and NCEs.
06
Write a note on photo stability testing.
05
Explain dissolution profile. Discuss the importance of comparison of the same and explain model independent method involving f1 and f2.
05
Q.7
Define shampoo and write its requirements. Enumerate shampoo additives.
06
Discuss the techniques for stabilization of pharmaceutical products against atmospheric oxygen.
05
Discuss hygroscopicity in context to preformulation study.
05
GUJARAT TECHNOLOGICAL UNIVERSITY
M. Ph. SEMESTER I EXAMINATION SUMMER 2018
Subject Code: 910102 Date: 05/05/2018
Subject Name: PHARMACEUTICAL FORMULATION DEVELOPMENT
BIOPHARMACEUTICS
Time: 02:30PM TO 05:30PM Total Marks: 80
Instructions:
1. Attempt any five questions.
2. Make suitable assumptions wherever necessary.
3. Figures to the right indicate full marks.
Q.1
Discuss hydrotrophy with respect to solubilization.
06
Discuss drug excipients compatibility study in context to preformulation studies.
05
Discuss the importance of dissolution study and enlist various dissolution test apparatus as per IP and USP respectively.
05
Q.2
Explain biological half life and total body clearance in context to pharmacokinetic parameters.
06
Enumerate the pharmaceutical factors affecting drug absorption and discuss disintegration time in said context.
05
Write the objectives of stability study and enumerate the factors affecting stability of formulation.
05
Q.3
Discuss formulation of tooth paste.
06
Write a note on levels of IVIVC.
05
Discuss the rationale for selecting preferred polymorphs/crystalline form with respect to preformulation study.
05
Q.4
Write a note on compartment models.
06
Explain four classes of BCS.
05
Explain "Order of reaction". Define zero order reaction and first order reaction and write examples and equation for calculating half life for each.
05
Q.5
Enumerate the methods of studying bioavailability and with the help of diagram, explain the importance of three major parameters of urinary excretion data obtained with single dose study.
06
Write the criteria for obtaining valid urinary excretion data.
05
Define IVIVC and discus its purposes.
05
Q. 6
Define preformulation and write the objectives of preformulation studies.
Give full forms of the following: DSC XRD FTIR OVIs DTA and NCEs.
06
Write a note on photo stability testing.
05
Explain dissolution profile. Discuss the importance of comparison of the same and explain model independent method involving f1 and f2.
05
Q.7
Define shampoo and write its requirements. Enumerate shampoo additives.
06
Discuss the techniques for stabilization of pharmaceutical products against atmospheric oxygen.
05
Discuss hygroscopicity in context to preformulation study.
05
Other Question Papers
Subjects
- advanced medicinal chemistry
- advanced organic chemistry-i
- advanced organic chemistry-ii
- advanced pharmacology ii
- advanced pharmacology-i
- advances in drug delivery system
- advances in pharmacology
- applied pharmacotherapeutics - ii
- applied pharmacotherapeutics-i
- audits and regulatory compliance
- biological evaluations & clinical research
- cellular and molecular pharmacology
- clinical and hospital pharmacy
- clinical pharmacy practice
- clinical research and pharmacy practice
- clinical research and regulatory affairs
- clinical research regulations
- cosmetic and cosmeceuticals
- documentation and regulatory writing
- drug design and discovery
- drug regulation and regulatory authority
- experimental design and patents
- global regulatory requirements
- gmp, glp and validation
- good manufacturing and good laboratory practice
- good manufacturing practice and process validation
- good regulatory practices
- hazards and safety management
- industrial pharmacy practice
- modern analytical techniques
- modern pharmaceutical analysis
- novel drug delivery system part-i
- novel drug delivery system-ii
- pharm. management -ii
- pharmaceutical analysis ii
- pharmaceutical and cosmetic analysis
- pharmaceutical formulation and development
- pharmaceutical formulation development and biopharmceutics
- pharmaceutical manufacturing technology
- pharmaceutical production management & technology
- pharmaceutical regulatory affairs
- pharmacological and toxicological screening methods-i
- pharmacological and toxicological screening methods-ii
- pharmacometrics and methods of biological evaluation of drugs
- pharmacotherapeutics
- principles of biopharmaceutics& pharmacokinetics
- product development and technology transfer
- quality control & quality assurance
- quality control and quality assurance
- quality management system
- regulatory affairs - i
- regulatory affairs and new drug applications
- regulatory aspects of hebbal and biologicals
- research methodology
- validation and product development